Quintet Private Bank Europe S.A. Sells 12,513 Shares of Intuitive Surgical, Inc. $ISRG

Quintet Private Bank Europe S.A. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 45,693 shares of the medical equipment provider’s stock after selling 12,513 shares during the quarter. Intuitive Surgical accounts for approximately 1.5% of Quintet Private Bank Europe S.A.’s holdings, making the stock its 20th biggest holding. Quintet Private Bank Europe S.A.’s holdings in Intuitive Surgical were worth $25,879,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ISRG. Blue Square Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 1.5% during the fourth quarter. Blue Square Asset Management LLC now owns 12,932 shares of the medical equipment provider’s stock worth $7,324,000 after purchasing an additional 188 shares during the period. Wealth Management Associates Inc. increased its holdings in Intuitive Surgical by 6.1% during the 4th quarter. Wealth Management Associates Inc. now owns 902 shares of the medical equipment provider’s stock valued at $511,000 after purchasing an additional 52 shares during the period. Evexia Wealth LLC bought a new position in Intuitive Surgical during the 4th quarter valued at approximately $248,000. Omnia Family Wealth LLC bought a new position in Intuitive Surgical during the 4th quarter valued at approximately $233,000. Finally, Beaumont Financial Advisors LLC lifted its holdings in Intuitive Surgical by 6.4% in the 4th quarter. Beaumont Financial Advisors LLC now owns 650 shares of the medical equipment provider’s stock worth $368,000 after buying an additional 39 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $452.07 on Friday. The firm has a market capitalization of $160.54 billion, a P/E ratio of 57.30, a P/E/G ratio of 3.49 and a beta of 1.68. The stock has a 50 day moving average price of $487.43 and a 200-day moving average price of $513.10. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm’s revenue was up 18.8% on a year-over-year basis. During the same period in the previous year, the company posted $2.21 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 105 shares of the stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president directly owned 660 shares in the company, valued at $326,673.60. The trade was a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 32,943 shares of company stock worth $17,279,568. Corporate insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on ISRG shares. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a research report on Wednesday, March 11th. Sanford C. Bernstein raised their price target on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Evercore reduced their price objective on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research report on Friday, January 23rd. Finally, Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.95.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.